Capital City Trust CO Abbott Laboratories Transaction History

Capital City Trust CO

$397 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $17,132 - $19,089	170 Added 3.67%	4,808 $524,000
Q1 2023 Apr 19, 2023	BUY	$96.86 - $114.01 $9,395 - $11,058	97 Added 2.14%	4,638 $469,000
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $19,012 - $22,304	200 Added 4.61%	4,541 $0
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $19,352 - $22,406	-200 Reduced 4.4%	4,341 $420,000
Q2 2022 Jul 15, 2022	BUY	$102.07 - $123.37 $43,583 - $52,678	427 Added 10.38%	4,541 $493,000
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $26,131 - $28,909	-224 Reduced 5.16%	4,114 $486,000
Q2 2021 Jul 23, 2021	SELL	$105.79 - $124.53 $21,263 - $25,030	-201 Reduced 4.43%	4,338 $503,000
Q1 2021 May 05, 2021	SELL	$108.84 - $128.23 $14,366 - $16,926	-132 Reduced 2.83%	4,539 $544,000
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $27,090 - $29,520	-258 Reduced 5.23%	4,671 $512,000
Q3 2020 Oct 21, 2020	BUY	$91.64 - $111.29 $733 - $890	8 Added 0.16%	4,929 $536,000
Q2 2020 Jul 15, 2020	BUY	$76.57 - $98.0 $3,062 - $3,920	40 Added 0.82%	4,921 $450,000
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $7,538 - $11,023	-120 Reduced 2.4%	4,881 $386,000
Q4 2019 Jan 15, 2020	SELL	$78.51 - $87.4 $27,007 - $30,065	-344 Reduced 6.44%	5,001 $435,000
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $818 - $887	10 Added 0.19%	5,345 $447,000
Q2 2019 Aug 02, 2019	SELL	$72.88 - $85.0 $9,474 - $11,050	-130 Reduced 2.38%	5,335 $449,000
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $9,178 - $10,397	-140 Reduced 2.5%	5,465 $395,000
Q3 2018 Oct 18, 2018	SELL	$60.81 - $73.36 $16,418 - $19,807	-270 Reduced 4.6%	5,605 $411,000
Q2 2018 Jul 20, 2018	SELL	$57.57 - $63.54 $13,241 - $14,614	-230 Reduced 3.77%	5,875 $358,000
Q1 2018 Apr 13, 2018	SELL	$56.27 - $63.62 $6,752 - $7,634	-120 Reduced 1.93%	6,105 $366,000
Q4 2017 Jan 12, 2018	SELL	$53.68 - $57.47 $4,294 - $4,597	-80 Reduced 1.27%	6,225 $355,000
Q4 2017 Jan 10, 2018	SELL	$53.68 - $57.47 $21,847 - $23,390	-407 Reduced 6.06%	6,305 $336,000
Q3 2017 Oct 11, 2017	BUY	$48.06 - $53.64 $322,578 - $360,031	6,712	6,712 $327,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.8 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.5 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.06 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.77 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.3 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital City Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital City Trust CO with notifications on news.

Account